Cargando…
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR),...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471113/ https://www.ncbi.nlm.nih.gov/pubmed/26083364 http://dx.doi.org/10.1371/journal.pone.0129210 |
_version_ | 1782376851031719936 |
---|---|
author | Fokam, Joseph Elat, Jean-Bosco N. Billong, Serge C. Kembou, Etienne Nkwescheu, Armand S. Obam, Nicolas M. Essiane, André Torimiro, Judith N. Ekanmian, Gatien K. Ndjolo, Alexis Shiro, Koulla S. Bissek, Anne C. Z-K. |
author_facet | Fokam, Joseph Elat, Jean-Bosco N. Billong, Serge C. Kembou, Etienne Nkwescheu, Armand S. Obam, Nicolas M. Essiane, André Torimiro, Judith N. Ekanmian, Gatien K. Ndjolo, Alexis Shiro, Koulla S. Bissek, Anne C. Z-K. |
author_sort | Fokam, Joseph |
collection | PubMed |
description | BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR), suggesting the need for pragmatic approaches in sustaining a successful ART performance. METHODS: A survey was conducted in 15 ART sites of the Centre and Littoral regions of Cameroon in 2013 (10 urban versus 05 rural settings; 8 at tertiary/secondary versus 7 at primary healthcare levels), evaluating HIVDR-early warning indicators (EWIs) as-per the 2012 revised World Health Organization’s guidelines: EWI(1) (on-time pill pick-up), EWI(2) (retention in care), EWI(3) (no pharmacy stock-outs), EWI(4) (dispensing practices), EWI(5) (virological suppression). Poor performance was interpreted as potential HIVDR. RESULTS: Only 33.3% (4/12) of sites reached the desirable performance for “on-time pill pick-up” (57.1% urban versus 0% rural; p<0.0001) besides 25% (3/12) with fair performance. 69.2% (9/13) reached the desirable performance for “retention in care” (77.8% urban versus 50% rural; p=0.01) beside 7.7% (1/13) with fair performance. Only 14.4% (2/13) reached the desirable performance of “no pharmacy stock-outs” (11.1% urban versus 25% rural; p=0.02). All 15 sites reached the desirable performance of 0% “dispensing mono- or dual-therapy”. Data were unavailable to evaluate “virological suppression” due to limited access to viral load testing (min-max: <1%-15%). Potential HIVDR was higher in rural (57.9%) compared to urban (27.8%) settings, p=0.02; and at primary (57.9%) compared to secondary/tertiary (33.3%) healthcare levels, p=0.09. CONCLUSIONS: Delayed pill pick-up and pharmacy stock-outs are major factors favoring HIVDR emergence, with higher risks in rural settings and at primary healthcare. Retention in care appears acceptable in general while ART dispensing practices are standard. There is need to support patient-adherence to pharmacy appointments while reinforcing the national drug supply system. |
format | Online Article Text |
id | pubmed-4471113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44711132015-06-29 Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations Fokam, Joseph Elat, Jean-Bosco N. Billong, Serge C. Kembou, Etienne Nkwescheu, Armand S. Obam, Nicolas M. Essiane, André Torimiro, Judith N. Ekanmian, Gatien K. Ndjolo, Alexis Shiro, Koulla S. Bissek, Anne C. Z-K. PLoS One Research Article BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR), suggesting the need for pragmatic approaches in sustaining a successful ART performance. METHODS: A survey was conducted in 15 ART sites of the Centre and Littoral regions of Cameroon in 2013 (10 urban versus 05 rural settings; 8 at tertiary/secondary versus 7 at primary healthcare levels), evaluating HIVDR-early warning indicators (EWIs) as-per the 2012 revised World Health Organization’s guidelines: EWI(1) (on-time pill pick-up), EWI(2) (retention in care), EWI(3) (no pharmacy stock-outs), EWI(4) (dispensing practices), EWI(5) (virological suppression). Poor performance was interpreted as potential HIVDR. RESULTS: Only 33.3% (4/12) of sites reached the desirable performance for “on-time pill pick-up” (57.1% urban versus 0% rural; p<0.0001) besides 25% (3/12) with fair performance. 69.2% (9/13) reached the desirable performance for “retention in care” (77.8% urban versus 50% rural; p=0.01) beside 7.7% (1/13) with fair performance. Only 14.4% (2/13) reached the desirable performance of “no pharmacy stock-outs” (11.1% urban versus 25% rural; p=0.02). All 15 sites reached the desirable performance of 0% “dispensing mono- or dual-therapy”. Data were unavailable to evaluate “virological suppression” due to limited access to viral load testing (min-max: <1%-15%). Potential HIVDR was higher in rural (57.9%) compared to urban (27.8%) settings, p=0.02; and at primary (57.9%) compared to secondary/tertiary (33.3%) healthcare levels, p=0.09. CONCLUSIONS: Delayed pill pick-up and pharmacy stock-outs are major factors favoring HIVDR emergence, with higher risks in rural settings and at primary healthcare. Retention in care appears acceptable in general while ART dispensing practices are standard. There is need to support patient-adherence to pharmacy appointments while reinforcing the national drug supply system. Public Library of Science 2015-06-17 /pmc/articles/PMC4471113/ /pubmed/26083364 http://dx.doi.org/10.1371/journal.pone.0129210 Text en © 2015 Fokam et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fokam, Joseph Elat, Jean-Bosco N. Billong, Serge C. Kembou, Etienne Nkwescheu, Armand S. Obam, Nicolas M. Essiane, André Torimiro, Judith N. Ekanmian, Gatien K. Ndjolo, Alexis Shiro, Koulla S. Bissek, Anne C. Z-K. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title | Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title_full | Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title_fullStr | Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title_full_unstemmed | Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title_short | Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations |
title_sort | monitoring hiv drug resistance early warning indicators in cameroon: a study following the revised world health organization recommendations |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471113/ https://www.ncbi.nlm.nih.gov/pubmed/26083364 http://dx.doi.org/10.1371/journal.pone.0129210 |
work_keys_str_mv | AT fokamjoseph monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT elatjeanboscon monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT billongsergec monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT kembouetienne monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT nkwescheuarmands monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT obamnicolasm monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT essianeandre monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT torimirojudithn monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT ekanmiangatienk monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT ndjoloalexis monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT shirokoullas monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations AT bissekanneczk monitoringhivdrugresistanceearlywarningindicatorsincameroonastudyfollowingtherevisedworldhealthorganizationrecommendations |